Paediatric relapsed CAR33+ acute myeloid leukaemia research hub

CAR T cells to fight acute myeloid leukaemia

This Phase I clinical trial tests a new cell therapy called BE-CAR33 for children and teenagers with acute myeloid leukaemia that has returned. Researchers use modified donor immune cells to clear out cancer cells before a planned stem cell transplant, aiming to keep the leukaemia from coming back.